Drugs / Intermediate acting Insulin (NPH)
Intermediate acting Insulin (NPH)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00590044 Comparator | Dec 2007 → Jun 2008 | diabetic ketoacidosis | Emory University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intermediate acting Insulin (NPH) | “Intermediate acting Insulin (NPH)” NCT00590044 ↗ |
| Known as | Isophane Insulin(NPH) | “Isophane Insulin(NPH)” NCT00590044 ↗ |
| Known as | NPH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00590044 ↗ |
| Route | Subcutaneous | “transitioned to subcutaneous NPH and regular insulin twice daily” PMID 19366972 ↗ Apr 2009 |